Ετικέτες

Τρίτη 9 Μαΐου 2017

Embryonic vascular disruption adverse outcomes: Linking high-throughput signaling signatures with functional consequences

Publication date: August 2017
Source:Reproductive Toxicology, Volume 71
Author(s): Robert G. Ellis-Hutchings, Raja S. Settivari, Alene T. McCoy, Nicole Kleinstreuer, Jill Franzosa, Thomas B. Knudsen, Edward W. Carney
Embryonic vascular disruption is an important adverse outcome pathway (AOP) as chemical disruption of cardiovascular development induces broad prenatal defects. High-throughput screening (HTS) assays aid AOP development although linking in vitro data to in vivo apical endpoints remains challenging. This study evaluated two anti-angiogenic agents, 5HPP-33 and TNP-470, across the ToxCastDB HTS assay platform and anchored the results to complex in vitro functional assays: the rat aortic explant assay (AEA), rat whole embryo culture (WEC), and the zebrafish embryotoxicity (ZET) assay. Both were identified as putative vascular disruptive compounds (pVDCs) in ToxCastDB and disrupted angiogenesis and embryogenesis in the functional assays. Differences were observed in potency and adverse effects: 5HPP-33 was embryolethal (WEC and ZET); TNP-470 produced caudal defects at lower concentrations. This study demonstrates how a tiered approach using HTS signatures and complex functional in vitro assays might be used to prioritize further in vivo developmental toxicity testing.



http://ift.tt/2ptN7Pr

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αναζήτηση αυτού του ιστολογίου